China's pharmaceutical market become foreign competition place2011.11.03 15:38
China's pharmaceutical marketand also to promote the state-owned, private and foreign pharmaceutical
by 2015 China will become the world's second largest pharmaceutical market after the United States China's policy of support for pharmaceutical development, talent
British pharmaceutical giant AstraZeneca announced on the 10th $ 200 million to build its global investment in Taizhou, the largest independent production base, product intravenous and oral solid tablet products to promote business development in China.
Shanghai Pharmaceutical plans to invest HK $ 6.0 billion which is from funds in pharmaceutical industry mergers and acquisitions, to enhance the core competitiveness.
because the policy support, but it is slightly inferior in the market flexibility. Despite the victory in the efficiency and services of private enterprises, who is trying to open a new situation, but with the competition in the enterprise and foreign pharmaceutical companies, they faced with financial bottlenecks and need to complement each other. In addition, foreign-funded enterprises in China still needs more desire Stock Watch to understand and master the local market, corporate culture, policies and regulations, and consumer habits.
By Qian Weiwei